Synthesis, characterization, reactivity, and catalytic potential of model vanadium(IV, V) complexes with benzimidazole-derived ONN donor ligands

Reaction between [VO(acac)(2)] and the ONN donor Schiff base Hsal-ambmz (I) (Hsal-ambmz = Schiff base obtained by the condensation of salicylaldehyde and 2-aminomethylbenzimidazole) resulted in the formation of the complexes [V(IV)O(acac)(sal-ambmz)] (1), [V(V)O(2)(acac-ambmz)] (2) (Hacac-ambmz = Schiff base derived from acetylacetone and 2-aminomethylbenzimidazole), and the known complex [V(IV)O(sal-phen)] (3) (H(2)sal-phen = Schiff base derived from salicylaldehyde and o-phenylenediamine). Similarly, [V(IV)O(acac)(sal-aebmz)] (7) has been isolated from the reaction with Hsal-aebmz (II) (Hsal-aebmz derived from salicylaldehyde and 2-aminoethylbenzimidazole). Aerial oxidation of the methanolic solutions/suspensions of 1 and 7 yielded the dioxovanadium(V) complexes [V(V)O(2)(sal-ambmz)] (4) and [V(V)O(2)(sal-aebmz)] (8), respectively. Reaction of VOSO(4) with II gave [{V(IV)O(sal-aebmz)}(2)SO(4)] (9) and [V(IV)O(sal-aebmz)(2)] (10), along with 3 and 8. Under similar reaction conditions, I gave only [{V(IV)O(sal-ambmz)}(2)SO(4)] (5) and 3 as major products. Treatment of 1 and 7 with benzohydroxamic acid (Hbha) yielded the mixed-chelate complexes [V(V)O(bha)(sal-ambmz)] (6) and [V(V)O(bha)(sal-aebmz)] (11). The crystal and molecular structures of 2, 3.1/2DMF, 7.1/4H(2)O, 8, 9.2H(2)O, 10, and 11 have been determined, confirming the ONN binding mode of the ligands. In complex 10, one of the ligands is coordinated through the azomethine nitrogen and phenolate oxygen only, leaving the benzimidazole group free. In the dinuclear complex 9, bridging functions are the phenolate oxygens from both of the ligands and two oxygens of the sulfato group. The unstable oxoperoxovanadium(V) complex [V(V)O(O(2))(sal-aebmz)] (12) has been prepared by treatment of 7 with aqueous H(2)O(2). Acidification of methanolic solutions of 7 and 10 lead to (reversible) protonation of the bemzimidazole, while 8 was converted to an oxo-hydroxo species. Complexes 2, 4, and 8 catalyze the oxidation of methyl phenyl sulfide to methyl phenyl sulfoxide and methyl phenyl sulfone, a reaction mimicking the sulfideperoxidase activity of vanadate-dependent haloperoxidases. These complexes are also catalytically active in the oxidation of styrene to styrene oxide, benzaldehyde, benzoic acid, and 1-phenylethane-1,2-diol.     

Structural models of vanadate-dependent haloperoxidases and their reactivity

Vanadium(V) complexes with hydrazone-based ONO and ONN donor ligands that partly model active-site structures of vanadate-dependent haloperoxidases have been reported. On reaction with [VO(acac)₂] (Hacac = acetylacetone) under nitrogen, these ligands generally provide oxovanadium(IV) complexes [VO(ONO)X] (X = solvent or nothing) and [VO(acac)(ONN)], respectively. Under aerobic conditions, these oxovanadium(IV) species undergo oxidation to give oxovanadium(V), dioxovanadium (V) or μ-oxobisoxovanadium(V) species depending upon the nature of the ligand. Anionic and neutral dioxovanadium(V) complexes slowly deoxygenate in methanol to give monooxo complexes [VO(OMe)(MeOH)(ONO)]. The anionic complexes [VO₂(ONO)]^- can also be convertedin situ on acidification to oxohydroxo complexes [VO(OH)(HONO)]⁺ and to peroxo complexes [VO(O₂)(ONO)]^-, and thus to the species assumed to be intermediates in the haloperoxidases activity of the enzymes. In the presence of catechol (H₂cat) and benzohydroxamic acid (H₂bha), oxovanadium (IV) complexes, [VO (acac)(ONN)] gave mixed-chelate oxovanadium(V) complexes [VO(cat)(ONN)] and [VO(bha)(ONN)] respectively. These complexes are not very stable in solution and slowly convert to the corresponding dioxo species [VO₂(ONN)] as observed by⁵¹V NMR and electronic absorption spectroscopic studies.     

Synthesis, characterisation, reactivity and in vitro antiamoebic activity of hydrazone based oxovanadium(IV), oxovanadium(V) and mu-bis(oxo)bis{oxovanadium(V)} complexes

Binuclear, mu-bis(oxo)bis{oxovanadium(V)} complexes [(VOL)2(mu-O)2](2 and 7)(where HL are the hydrazones Hacpy-nah I or Hacpy-fah II; acpy = 2-acetylpyridine, nah = nicotinic acid hydrazide and fah = 2-furoic acid hydrazide) were prepared by the reaction of [VO(acac)2] and the ligands in methanol followed by aerial oxidation. The paramagnetic intermediate complexes [VO(acac)(acpy-nah)](1) and [VO(acac)(acpy-fah)](6) have also been isolated. Treatment of [VO(acac)(acpy-nah)] and [VO(acac)(acpy-fah)] with aqueous H2O2 yields the oxoperoxovanadium(V) complexes [VO(O2)(acpy-nah)](3) and [VO(O2)(acpy-fah)](8). In the presence of catechol (H2cat) or benzohydroxamic acid (H2bha), 1 and 6 give the mixed chelate complexes [VO(cat)L](HL =I: 4, HL =II: 9) or [VO(bha)L](HL =I: 5, HL =II: 10). Complexes 4, 5, 9 and 10 slowly convert to the corresponding oxo-mu-oxo species 2 and 7 in DMF solution. Ascorbic acid enhances this conversion under aerobic conditions, possibly through reduction of these complexes with concomitant removal of coordinated catecholate or benzohydroxamate. Acidification of 7 with HCl dissolved in methanol afforded a hydroxo(oxo) complex. The crystal and molecular structure of 2.1.5H2O has been determined, and the structure of 7 re-determined, by single crystal X-ray diffraction. Both of these binuclear complexes contain the uncommon asymmetrical {VO(mu-O)}2 diamond core. The in vitro tests of the antiamoebic activity of ligands I and II and their binuclear complexes 2 and 7 against the protozoan parasite Entamoeba histolytica show that the ligands have no amoebicidal activity while their vanadium complexes 2 and 7 display more effective amoebicidal activity than the most commonly used drug metronidazole (IC50 values are 1.68 and 0.45 microM, respectively vs 1.81 microM for metronidazole). Complexes 2 and 7 catalyse the oxidation of styrene and ethyl benzene effectively. Oxidation of styrene, using H2O2 as an oxidant, gives styrene epoxide, 2-phenylacetaldehyde, benzaldehyde, benzoic acid and 1-phenyl-ethane-1,2-diol, while ethyl benzene yields benzyl alcohol, benzaldehyde and 1-phenyl-ethane-1,2-diol.     

Synthesis, characterisation and catalytic potential of hydrazonato-vanadium(V) model complexes with [VO]3+ and [VO2]+ cores

Reaction between [VO(acac)2] and H2L (H2L are the hydrazones H2sal-nah I or H2sal-fah II; sal = salicylaldehyde, nah = nicotinic acid hydrazide and fah = 2-furoic acid hydrazide) in methanol leads to the formation of oxovanadium(IV) complexes [VOL.H2O](H2L = I: 1, H2L = II: 4). Aerial oxidation of the methanolic solutions of 1 and 4 yields the dinuclear oxo-bridged monooxovanadium(V) complexes [{VOL}2mu-O](H2L = I: 2, H2L = II: 5). These dinuclear complexes slowly convert, in excess methanol, to [VO(OMe)(MeOH)L](H(2)L = I: 9, H(2)L = II: 10), the crystal and molecular structures of which have been determined, confirming the ONO binding mode of the dianionic ligands in their enolate form. Reaction of aqueous K[VO3] with the ligands at pH ca. 7.5 results in the formation of [K(H2O)][VO2L](H2L = I: 3, H2L = II: 6). Treatment of 3 and 6 with H2O2 yields (unstable) oxoperoxovanadium(v) complexes K[VO(O2)L], the formation of which has been monitored spectrophotometrically. Acidification of methanolic solutions of 3 and 6 with HCl affords oxohydroxo complexes, while the neutral complexes [VO2(Hsal-nah)] 7 and [VO2(Hsal-fah)] 8 were isolated on treatment of aqueous solutions of 3 and 6 with HClO4. These complexes slowly transform into 9 and 10 in methanol, as confirmed by 1H, 13C and 51V NMR. The anionic complexes 3 and 6 catalyse the oxidative bromination of salicylaldehyde in water in the presence of H2O2/KBr to 5-bromosalicylaldehyde and 3,5-dibromosalicylaldehyde, a reaction similar to that exhibited by vanadate-dependent haloperoxidases. They are also catalytically active for the oxidation of benzene to phenol and phenol to catechol and p-hydroquinone.     

Synthetically persistent, self assembled [V(IV)2V(V)4] polyoxovanadates: facile synthesis, structure and magnetic analysis

Slow diffusion in a H-tube at room temperature of a methanolic solution of [VO(acac)(2)] (Hacac = acetylacetone) and 1,10-phenanthroline (phen) or 2,2'-bipyridine (bipy) into an aqueous solution of sodium pyrophosphate (Na(4)P(2)O(7)) resulted in the serendipitous formation of X-ray quality crystals of mixed-valent, hexameric oxovanadates of general formula [V(6)O(12)(OCH(3))(4)(L)(4)]·solv [L = 1,10-phenanthroline (phen) for 1· 2CH(3)OH · 4H(2)O (1a), and 2,2'-bipyridine (bipy) for 2· 4H(2)O (2a)]. These were characterized by single-crystal X-ray diffraction, IR, elemental and thermogravimetric analysis (TGA). A facile, rationalized synthetic route for the isolation of 1a and 2a could be established following structural determination, involving NaOH in place of Na(4)P(2)O(7) as pH modulator. The use of distilled water (pH 7) as methanolic co-solvent also resulted in crystallization of the two complexes, proving the presence of a base in the reaction scheme is not vital, with slightly pH-depended yields noted for 2a only. A survey of the literature revealed the occurrence of several other procedures, from classical methods to hydrothermal routes, leading to different solvates of 1, the crystal structure of 2 being unreported in any form to date. The precise nature of the molecular assembly in these type of hybrid organic-inorganic poly-vanadates is contradictory in published reports. On the basis of newly acquired high resolution crystal data and supported by magnetic investigation of the samples, we propose herein a formulation as [(V(IV)O)(2)(V(V)O(2))(4)(μ(3)-O)(2)(μ-OCH(3))(4)(L)(4)], with two oxovanadyl(IV) and four dioxovanadyl(V) units per molecule. A net ferromagnetic coupling between the two isolated V(IV) metal centers was measured with literature-consistent J values of +16.1(1) and +19.7(1) cm(-1) for 1a and 2a, respectively [H = -JS(A)·S(B) + S(A)·D·S(B) + βH (g(A)S(A) + g(B)S(B))], suggesting that crystal packing forces do not significantly influence the magnetic properties of this class of materials. A facile route toward the synthesis of the fully-oxidized [V(V)(4)O(8)(CH(3)O)(4)(bipy)(2)] and [V(V)(4)O(6)(CH(3)O)(6)(acac)(2)] tetraoxovanadates is also reported.     

Investigation of mixed oxidation state cyanide-bridged Re(V)oxo (acac(2)en/pn) and Re(I)(bipy)(CO)3 complexes

A series of cyanide-bridged complexes that combine a low-valent photoacceptor rhenium(I) metal center with an electroactive midvalent rhenium(V) complex were prepared. The synthesis involved the preparation of novel asymmetric rhenium(V) oxo compounds, cis-Re(V)O(CN)(acac(2)en) (1) and cis-Re(V)O(CN)(acac(2)pn) (2), formed by reacting trans-[Re(V)O(OH(2))(acac(2)en)]Cl or trans-Re(V)O(acac(2)pn)Cl with [NBu(4)][CN]. The μ-bridged cyanide mixed-oxidation Re(V)-Re(I) complexes were prepared by incubating the asymmetric complexes, 1 or 2, with fac-[Re(I)(bipy)(CO)(3)][OTf] to yield cis-[Re(V)O(acac(2)en)(μ-CN-1κC:2κN)-fac-Re(I)(bipy)(CO)(3)][PF(6)] (3) and [cis-Re(V)O(acac(2)pn)(μ-CN-1κC:2κN)-fac-Re(I)(bipy)(CO)(3)][PF(6)] (4), respectively.     

Synthesis, characterization, and reactivity of mononuclear O,N-chelated vanadium(IV) and -(III) complexes of methyl 2-Aminocyclopent-1-ene-1-dithiocarboxylate based ligand: reporting an example of conformational isomerism in the solid state

Vanadium(IV) and -(III) complexes of a tetradentate N(2)OS Schiff base ligand H(2)L [derived from methyl 2-((beta-aminoethyl)amino)cyclopent-1-ene-1-dithiocarboxylate and salicylaldehyde] are reported. In all the complexes, the ligand acts in a bidentate (N,O) fashion leaving a part containing the N,S donor set uncoordinated. The oxovanadium(IV) complex [VO(HL)(2)] (1) is obtained by the reaction between [VO(acac)(2)] and H(2)L. In the solid state, compound 1 has two conformational isomers 1a and 1b; both have been characterized by X-ray crystallography. Compound 1a has the syn conformation that enforces the donor atoms around the metal center to adopt a distorted tbp structure (tau = 0.55). Isomer 1b on the other hand has an anti conformation with almost a regular square pyramidal geometry (tau = 0.06) around vanadium. In solution, however, 1 prefers to be in the square pyramidal form. A second variety of vanadyl complex [VO(L(cyclic))(2)](I(3))(2) (2) with a new bidentate O,N donor ligand involving isothiazolium moiety has been obtained by a ligand-based oxidation of the precursor complex 1 with iodine. Preliminary X-ray and FAB mass spectroscopic data of 2 have supported the formation of a heterocyclic moiety by a ring closure reaction involving a N-S bond. Vanadium(III) complex [V(acac)(HL)(2)] (3) has been obtained through partial ligand displacement of [V(acac)(3)] with H(2)L. Compound 3 has almost a regular octahedral structure completed by two bidentate HL ligands along with an acetylacetonate molecule. Electronic spectra, magnetism, EPR, and redox properties of these compounds are reported.     

Polymer-anchored peroxo compounds of vanadium(V) and molybdenum(VI): synthesis, stability, and their activities with alkaline phosphatase and catalase

We generated a series of new polymer-bound peroxo complexes of vanadium(V) and molybdenum(VI) of the type [VO(O(2))(2)(sulfonate)]-PSS [PSS = poly(sodium 4-styrene sulfonate)] (PV(3)), [V(2)O(2)(O(2))(4)(carboxylate)VO(O(2))(2)(sulfonate)]-PSSM [PSSM = poly(sodium styrene sulfonate-co-maleate)] (PV(4)), [Mo(2)O(2)(O(2))(4)(carboxylate)]-PA [PA = poly(sodium acrylate)] (PMo(1)), [MoO(O(2))(2)(carboxylate)]-PMA [PMA = poly(sodium methacrylate)] (PMo(2)), and [MoO(O(2))(2)(amide)]-PAm [PAm = poly(acrylamide)] (PMo(3)) by reacting V(2)O(5) (for PV(3) and PV(4)) or H(2)MoO(4) (for PMo(1), PMo(2), and PMo(3)) with H(2)O(2) and the respective water-soluble macromolecular ligand at pH 5-6. The compounds were characterized by elemental analysis (CHN and energy-dispersive X-ray spectroscopy), spectral studies (UV-vis, IR, (13)C NMR, (51)V NMR, and (95) Mo NMR), thermal (TGA) as well as scanning electron micrographs (SEM), and EDX analysis. It has been demonstrated that compounds retain their structural integrity in solutions of a wide range of pH values and are approximately 100 times weaker as substrate to the enzyme catalase relative to H(2)O(2), its natural substrate. The effect of the title compounds, along with previously reported compounds [V(2)O(2)(O(2))(4)(carboxylate)]-PA (PV(1)) and [VO(O(2))(2)(carboxylate)]-PMA (PV(2)) on rabbit intestine alkaline phosphatase (ALP) has been investigated and compared with the effect induced by the free diperoxometallates viz. Na[VO(O(2))(2)(H(2)O)] (DPV), [MoO(O(2))(2)(glycine)(H(2)O)] (DMo(1)), and [MoO(O(2))(2)(asparagine)(H(2)O)] (DMo(2)). It has been observed that although all the compounds tested are potent inhibitors of the enzyme, the polymer-bound and neat complexes act via distinct mechanisms. Each of the macromolecular compounds is a classical noncompetitive inhibitor of ALP. In contrast, the action of neat pV and heteroligand pMo compounds on the enzyme function is consistent with a mixed type of inhibition.     

Reactivity of rhenium(V) oxo Schiff base complexes with phosphine ligands: rearrangement and reduction reactions

The symmetric rhenium(V) oxo Schiff base complexes trans-[ReO(OH2)(acac2en)]Cl and trans-[ReOCl(acac2pn)], where acac2en and acac2pn are the tetradentate Schiff base ligands N,N'-ethylenebis(acetylacetone) diimine and N,N'-propylenebis(acetylacetone) diimine, respectively, were reacted with monodentate phosphine ligands to yield one of two unique cationic phosphine complexes depending on the ligand backbone length (en vs pn) and the identity of the phosphine ligand. Reduction of the Re(V) oxo core to Re(III) resulted on reaction of trans-[ReO(OH2)(acac2en)]Cl with triphenylphosphine or diethylphenylphosphine to yield a single reduced, disubstituted product of the general type trans-[Re(III)(PR3)2(acac2en)]+. Rather unexpectedly, a similar reaction with the stronger reducing agent triethylphosphine yielded the intramolecularly rearranged, asymmetric cis-[Re(V)O(PEt3)(acac2en)]+ complex. Reactions of trans-[Re(V)O(acac2pn)Cl] with the same phosphine ligands yielded only the rearranged asymmetric cis-[Re(V)O(PR3)(acac2pn)]+ complexes in quantitative yield. The compounds were characterized using standard spectroscopic methods, elemental analyses, cyclic voltammetry, and single-crystal X-ray diffraction. The crystallographic data for the structures reported are as follows: trans-[Re(III)(PPh3)2(acac2en)]PF6 (H48C48N2O2P2Re.PF6), 1, triclinic (P), a = 18.8261(12) A, b = 16.2517(10) A, c = 15.4556(10) A, alpha = 95.522(1) degrees , beta = 97.130(1) degrees , gamma = 91.350(1) degrees , V = 4667.4(5) A(3), Z = 4; trans-[Re(III)(PEt2Ph)2(acac2en)]PF6 (H48C32N2O2P2Re.PF6), 2, orthorhombic (Pccn), a = 10.4753(6) A, b =18.4315(10) A, c = 18.9245(11) A, V = 3653.9(4) A3, Z = 4; cis-[Re(V)O(PEt3)(acac2en)]PF6 (H33C18N2O3PRe.1.25PF6, 3, monoclinic (C2/c), a = 39.8194(15) A, b = 13.6187(5) A, c = 20.1777(8) A, beta = 107.7730(10) degrees , V = 10419.9(7) A3, Z = 16; cis-[Re(V)O(PPh3)(acac2pn)]PF6 (H35C31N2O3PRe.PF6), 4, triclinic (P), a = 10.3094(10) A, b =12.1196(12) A, c = 14.8146(15) A, alpha = 105.939(2) degrees , beta = 105.383(2) degrees , gamma = 93.525(2) degrees , V = 1698.0(3) A3, Z = 2; cis-[Re(V)O(PEt2Ph)(acac2pn)]PF6 (H35C23N2O3PRe.PF6), 5, monoclinic (P2(1)/n), a = 18.1183(18) A, b = 11.580(1) A, c = 28.519(3) A, beta = 101.861(2) degrees , V = 5855.9(10) A(3), Z = 4.     

Monomeric oxovanadium(IV) compounds of the general formula cis-[V(IV)(=O)(X)(L(NN))(2)](+/0) [X = OH(-), Cl(-), SO(4)(2)(-) and L(NN) = 2,2'-bipyridine (bipy) or 4,4'-disubstituted bipy

Reaction of [V(IV)OCl(2)(THF)(2)] in aqueous solution with 2 equiv of AgBF(4) or AgSbF(6) and then with 2 equiv of 2,2'-bipyridine (bipy), 4,4'-di-tert-butyl-2,2'-bipyridine (4,4'-dtbipy), or 4,4'-di-methyl-2,2'-bipyridine (4,4'-dmbipy) affords compounds of the general formula cis-[V(IV)O(OH)(L(NN))(2)]Y [where L(NN) = bipy, Y = BF(4)(-) (1), L(NN) = 4,4'-dtbipy, Y = BF(4)(-) (2.1.2H(2)O), L(NN) = 4,4'-dmbipy, Y = BF(4)(-) (3.2H(2)O), and L(NN) = 4,4'-dtbipy, Y = SbF(6)(-) (4)]. Sequential addition of 1 equiv of Ba(ClO(4))(2) and then of 2 equiv of bipy to an aqueous solution containing 1 equiv of V(IV)OSO(4).5H(2)O yields cis-[V(IV)O(OH)(bipy)(2)]ClO(4) (5). The monomeric compounds 1-5 contain the cis-[V(IV)O(OH)](+) structural unit. Reaction of 1 equiv of V(IV)OSO(4).5H(2)O in water and of 1 equiv of [V(IV)OCl(2)(THF)(2)] in ethanol with 2 equiv of bipy gives the compounds cis-[V(IV)O(OSO(3))(bipy)(2)].CH(3)OH.1.5H(2)O (6.CH(3)OH.1.5H(2)O) and cis-[V(IV)OCl(bipy)(2)]Cl (7), respectively, while reaction of 1 equiv of [V(IV)OCl(2)(THF)(2)] in CH(2)Cl(2) with 2 equiv of 4,4'-dtbipy gives the compound cis-[V(IV)OCl(4,4'-dtbipy)(2)]Cl.0.5CH(2)Cl(2) (8.0.5CH(2)Cl(2)). Compounds cis-[V(IV)O(BF(4))(4,4'-dtbipy)(2)]BF(4) (9), cis-[V(IV)O(BF(4))(4,4'-dmbipy)(2)]BF(4) (10), and cis-[V(IV)O(SbF(6))(4,4'-dtbipy)(2)]SbF(6) (11) were synthesized by sequential addition of 2 equiv of 4,4'-dtbipy or 4,4'-dmbipy and 2 equiv of AgBF(4) or AgSbF(6) to a dichloromethane solution containing 1 equiv of [V(IV)OCl(2)(THF)(2)]. The crystal structures of 2.1.2H(2)O, 6.CH(3)OH.1.5H(2)O, and 8.0.5CH(2)Cl(2) were demonstrated by X-ray diffraction analysis. Crystal data are as follows: Compound 2.1.2H(2)O crystallizes in the orthorhombic space group Pbca with (at 298 K) a = 21.62(1) A, b = 13.33(1) A, c = 27.25(2) A, V = 7851(2) A(3), Z = 8. Compound 6.CH(3)OH.1.5H(2)O crystallizes in the monoclinic space group P2(1)/a with (at 298 K) a = 12.581(4) A, b = 14.204(5) A, c = 14.613(6) A, beta = 114.88(1) degrees, V = 2369(1), Z = 4. Compound 8.0.5CH(2)Cl(2) crystallizes in the orthorhombic space group Pca2(1) with (at 298 K) a = 23.072(2) A, b = 24.176(2) A, c = 13.676(1) A, V = 7628(2) A(3), Z = 8 with two crystallographically independent molecules per asymmetric unit. In addition to the synthesis and crystallographic studies, we report the optical, infrared, magnetic, conductivity, and CW EPR properties of these oxovanadium(IV) compounds as well as theoretical studies on [V(IV)O(bipy)(2)](2+) and [V(IV)OX(bipy)(2)](+/0) species (X = OH(-), SO(4)(2)(-), Cl(-)).     

N,N'-ethylenebis(pyridoxylideneiminato) and N,N'-ethylenebis(pyridoxylaminato): synthesis, characterization, potentiometric, spectroscopic, and DFT studies of their vanadium(IV) and vanadium(V) complexes

The Schiff base N,N'-ethylenebis(pyridoxylideneiminato) (H(2)pyr(2)en, 1) was synthesized by reaction of pyridoxal with ethylenediamine; reduction of H(2)pyr(2)en with NaBH(4) yielded the reduced Schiff base N,N'-ethylenebis(pyridoxylaminato) (H(2)Rpyr(2)en, 2); their crystal structures were determined by X-ray diffraction. The totally protonated forms of 1 and 2 correspond to H(6)L(4+), and all protonation constants were determined by pH-potentiometric and (1)H NMR titrations. Several vanadium(IV) and vanadium(V) complexes of these and other related ligands were prepared and characterized in solution and in the solid state. The X-ray crystal structure of [V(V)O(2)(HRpyr(2)en)] shows the metal in a distorted octahedral geometry, with the ligand coordinated through the N-amine and O-phenolato moieties, with one of the pyridine-N atoms protonated. Crystals of [(V(V)O(2))(2)(pyren)(2)].2 H(2)O were obtained from solutions containing H(2)pyr(2)en and oxovanadium(IV), where Hpyren is the "half" Schiff base of pyridoxal and ethylenediamine. The complexation of V(IV)O(2+) and V(V)O(2) (+) with H(2)pyr(2)en, H(2)Rpyr(2)en and pyridoxamine in aqueous solution were studied by pH-potentiometry, UV/Vis absorption spectrophotometry, as well as by EPR spectroscopy for the V(IV)O systems and (1)H and (51)V NMR spectroscopy for the V(V)O(2) systems. Very significant differences in the metal-binding abilities of the ligands were found. Both 1 and 2 act as tetradentate ligands. H(2)Rpyr(2)en is stable to hydrolysis and several isomers form in solution, namely cis-trans type complexes with V(IV)O, and alpha-cis- and beta-cis-type complexes with V(V)O(2). The pyridinium-N atoms of the pyridoxal rings do not take part in the coordination but are involved in acid-base reactions that affect the number, type, and relative amount of the isomers of the V(IV)O-H(2)Rpyr(2)en and V(V)O(2)-H(2)Rpyr(2)en complexes present in solution. DFT calculations were carried out and support the formation and identification of the isomers detected by EPR or NMR spectroscopy, and the strong equatorial and axial binding of the O-phenolato in V(IV)O and V(V)O(2) complexes. Moreover, the DFT calculations done for the [V(IV)O(H(2)Rpyr(2)en)] system indicate that for almost all complexes the presence of a sixth equatorial or axial H(2)O ligand leads to much more stable compounds.     

Synthesis and characterization of novel rhenium(V) tetradentate N2O2 Schiff base monomer and dimer complexes

Several rhenium(V) oxo complexes with tetradentate N(2)O(2) Schiff base ligands were synthesized and characterized. The general synthetic procedure involved reaction of [NBu(4)][ReOCl(4)] with a tetradentate Schiff base ligand (L(1) = N,N'-ethylenebis(acetylacetoneimine), (acac(2)en) or L(2) = N,N'-propylenebis(acetylacetoneimine) (acac(2)pn)) in ethanol solution to generate complexes of the form trans-ReOX(L) where X = Cl(-), MeO(-), ReO(4)(-), or H(2)O. The product isolated from the reaction was found to be dependent on the reaction conditions, in particular the presence or absence of water and/or base. The mu-oxo-Re(2)O(3)(L)(2) dimers were synthesized and characterized for chemical and structural comparison to the related monomers. Conversion of the monomer to its dimer analogue was followed qualitatively by spectrophotometry. The complexes were characterized by (1)H and (13)C NMR, UV-vis, and IR spectroscopy, elemental analysis, and single crystal X-ray diffraction. The crystallographic data reported for the structures are as follows: trans-[ReO(OH(2))(acac(2)en)]Cl (H(20)C(12)ClN(2)O(4)Re) 1, triclinic (Ponemacr;), a = 7.2888(6) A, b = 9.8299(8) A, c = 10.8195(9) A, alpha = 81.7670(10) degrees, beta = 77.1510(10) degrees, gamma = 87.6200(10) degrees, V = 747.96(11) A(3), Z = 2; trans-[ReO(OReO(3))(acac(2)en)] (H(18)C(12)N(2)O(7)Re(2)) 2, monoclinic (P2(1)/c), a = 7.5547(4) A, b = 8.7409(5) A, c= 25.7794(13) A, beta = 92.7780(10) degrees, V = 1700.34(16) A(3), Z = 4; trans-[ReOCl(acac(2)pn)] (H(20)C(13)N(2)O(3)ClRe) 3, monoclinic (P2(1)/c), a = 8.1628(5) A, b = 13.0699(8) A, c = 28.3902(17) A, beta = 97.5630(10) degrees, V = 3002.5(3) A(3), Z = 8; trans-[ReO(OMe)(acac(2)pn)] (H(23)C(14)N(2)O(4)Re) 4, monoclinic (P2(1)/c), a = 6.7104(8) A, b = 27.844(3) A, c = 8.2292(9) A, beta = 92.197(2) degrees, V = 1536.4(3) A(3), Z = 4; trans-[mu-oxo-Re(2)O(3)(acac(2)en)(2)] (H(36)C(24)N(4)O(7)Re(2)) 5, monoclinic (P2(1)/n), a = 9.0064(5) A, b = 12.2612(7) A, c = 12.3695(7) A, beta = 90.2853(10) degrees, V = 1365.94(13) A(3), Z = 2; and trans-[mu-oxo Re(2)O(3)(acac(2)pn)(2)] (H(40)C(26)N(4)O(7)Re(2)) 6, monoclinic (P2(1)/n), a = 9.1190(5) A, b = 12.2452(7) A, c = 12.8863(8) A, beta = 92.0510(10) degrees, V = 1438.01(14) A(3), Z = 2.     

Coordination and Redox Chemistry of Substituted-Polypyridyl Complexes of Ruthenium

The complexes [Ru(tpy)(acac)(Cl)], [Ru(tpy)(acac)(H(2)O)](PF(6)) (tpy = 2,2',2"-terpyridine, acacH = 2,4 pentanedione) [Ru(tpy)(C(2)O(4))(H(2)O)] (C(2)O(4)(2)(-) = oxalato dianion), [Ru(tpy)(dppene)(Cl)](PF(6)) (dppene = cis-1,2-bis(diphenylphosphino)ethylene), [Ru(tpy)(dppene)(H(2)O)](PF(6))(2), [Ru(tpy)(C(2)O(4))(py)], [Ru(tpy)(acac)(py)](ClO(4)), [Ru(tpy)(acac)(NO(2))], [Ru(tpy)(acac)(NO)](PF(6))(2), and [Ru(tpy)(PSCS)Cl] (PSCS = 1-pyrrolidinedithiocarbamate anion) have been prepared and characterized by cyclic voltammetry and UV-visible and FTIR spectroscopy. [Ru(tpy)(acac)(NO(2))](+) is stable with respect to oxidation of coordinated NO(2)(-) on the cyclic voltammetric time scale. The nitrosyl [Ru(tpy)(acac)(NO)](2+) falls on an earlier correlation between nu(NO) (1914 cm(-)(1) in KBr) and E(1/2) for the first nitrosyl-based reduction 0.02 V vs SSCE. Oxalate ligand is lost from [Ru(II)(tpy)(C(2)O(4))(H(2)O)] to give [Ru(tpy)(H(2)O)(3)](2+). The Ru(III/II) and Ru(IV/III) couples of the aqua complexes are pH dependent. At pH 7.0, E(1/2) values are 0.43 V vs NHE for [Ru(III)(tpy)(acac)(OH)](+)/[Ru(II)(tpy)(acac)(H(2)O)](+), 0.80 V for [Ru(IV)(tpy)(acac)(O)](+)/[Ru(III)(tpy)(acac)(OH)](+), 0.16 V for [Ru(III)(tpy)(C(2)O(4))(OH)]/[Ru(II)(tpy)(C(2)O(4))(H(2)O)], and 0.45 V for [Ru(IV)(tpy)(C(2)O(4))(O)]/[Ru(III)(tpy)(C(2)O(4))(OH)]. Plots of E(1/2) vs pH define regions of stability for the various oxidation states and the pK(a) values of aqua and hydroxo forms. These measurements reveal that C(2)O(4)(2)(-) and acac(-) are electron donating to Ru(III) relative to bpy. Comparisons with redox potentials for 21 related polypyridyl couples reveal the influence of ligand changes on the potentials of the Ru(IV/III) and Ru(III/II) couples and the difference between them, DeltaE(1/2). The majority of the effect appears in the Ru(III/II) couple. ()A linear correlation exists between DeltaE(1/2) and the sum of a set of ligand parameters defined by Lever et al., SigmaE(i)(L(i)), for the series of complexes, but there is a dramatic change in slope at DeltaE(1/2) approximately -0.11 V and SigmaE(i)(L(i)) = 1.06 V. Extrapolation of the plot of DeltaE(1/2) vs SigmaE(i)(L(i)) suggests that there may be ligand environments in which Ru(III) is unstable with respect to disproportionation into Ru(IV) and Ru(II). This would make the two-electron Ru(IV)O/Ru(II)OH(2) couple more strongly oxidizing than the one-electron Ru(IV)O/Ru(III)OH couple.     

Dioxo- and oxovanadium(V) complexes of thiohydrazone ONS donor ligands: synthesis, characterization, reactivity, and antiamoebic activity

As a contribution to the development of novel vanadium complexes with pharmacologically interesting properties, two neutral dioxovanadium(V) complexes [VO2(Hpydx-sbdt)] (1) and [VO2(Hpydx-smdt)] (3) [H2pydx-sbdt (I) and H2pydx-smdt (II) are the Schiff bases derived from pyridoxal and S-benzyl- or S-methyldithiocarbazate] have been synthesized by the reaction of [VO(acac)2] and the potassium salts of the ligands in methanol followed by aerial oxidation. Heating of the methanolic solutions of these complexes yields the oxo-bridged binuclear complexes [{VO(pydx-sbdt)}2mu-O] (2) and [{VO(pydx-smdt)}2mu-O] (4). The crystals and molecular structures of 1, 3 x 1.5H2O, and 4 x 2CH3OH have been determined, confirming the ONS binding mode of the dianionic ligands in their thioenolate form. The ring nitrogen of the pyridoxal moiety is protonated in complexes 1 and 3. Acidification of 1 and 3 with HCl dissolved in methanol afforded oxohydroxo complexes, while in a methanolic KOH solution, the corresponding dioxo species K[VO2(pydx-sbdt/smdt)] are formed. Treatment of 1 and 3 with H2O2 yields (unstable) oxoperoxovanadium(V) complexes, the formation of which has been established spectrophotometrically. In vitro antiamoebic activities (against HM1:1MSS strain of Entamoeba histolytica) were established for all of the dioxo- and oxovanadium(V) complexes. The complexes 1, 2, and 4 were more effective than metronidazole, a commonly used drug against amoebiasis, suggesting that oxovanadium(V) complexes derived from thiohydrazones may open a new dimension in the therapy of amoebiasis.     

NMR and theoretical investigations on the structures and dynamics of octahedral bis(chelate)dichloro V(III) compounds isolated by an unusual reduction of non-oxo V(IV) species

Reaction of the non-oxo V(IV) species [V(IV)Cl(2)(L(OO))(2)] [L(OO) = acetylacetonate (acac(-)) or benzoylacetonate (bzac(-))] with a chelate nitrogen-donor ligand L(NN) in acetonitrile leads to the reduction of V(IV) to V(III) and the formation of the mononuclear V(III) compounds of the general formula [V(III)Cl(2)(L(OO))(L(NN))] (L(OO) and L(NN) are acac(-) and bipy for 1; acac- and 5,5'-me(2)bipy for 2; acac(-) and 4,4'-tb(2)bipy for 3; acac(-) and phen for 4; bzac(-) and bipy for 5; bzac(-) and phen for 6). The reduction of the V(IV) complexes was monitored by GC-MS and (1)H NMR spectroscopy. Both one- and two-dimensional (2D COSY and 2D EXSY) (1)H NMR techniques were used to assign the observed (1)H NMR resonances of 1-6 in CD(2)Cl(2) or CDCl(3) solution. It appeared that in solution these V(III) complexes form two isomers which are in equilibrium: cis-[V(III)Cl(2)(L(OO))(L(NN))] <==> trans-[V(III)Cl(2)(L(OO))(L(NN))]. 2D EXSY cross-peaks were clearly observed between bipy- and acac-hydrogen atoms of the two geometrical isomers of 1-3 as well as between bipy and acac(-) protons of the cis isomer, indicating a dynamic process that corresponds to cis-trans isomerization and a cis-cis racemization. The thermodynamic and kinetic parameters of the equilibrium between these two isomers were calculated for compounds 1 and 2 by using variable temperature (VT) NMR data. Both cis-trans isomerization and cis-cis racemization processes probably proceed with an intramolecular twist mechanism involving a trigonal prismatic transition state. Density functional calculations (DFT) also indicated such a rearrangement mechanism.     

Tetra- and dinuclear nickel(II)-vanadium(IV/V) heterometal complexes of a phenol-based N2O2 ligand: synthesis, structures, and magnetic and redox properties

The tetra- and binuclear heterometallic complexes of nickel(II)-vanadium(IV/V) combinations involving a phenol-based primary ligand, viz., N,N'-dimethyl-N,N'-bis(2-hydroxy-3,5-dimethylbenzyl)ethylenediamine (H2L1), are reported in this work. Carboxylates and beta-diketonates have been used as ancillary ligands to obtain the tetranuclear complexes [Ni(II)(2)V(V)(2)(RCOO)(2)(L(1))(2)O(4)] (R = Ph, 1; R = Me(3)C, 2) and the binuclear types [(beta-diket)Ni(II)L(1)V(IV)O(beta-diket)] (3 and 4), respectively. X-ray crystallography shows that the tetranuclear complexes are constructed about an unprecedented heterometallic eight-membered Ni(2)V(2)O(4) core in which the (L(1))(2)- ligands are bound to the Ni center in a N(2)O(2) mode and simultaneously bridge a V atom via the phenoxide O atoms. The cis-N(2)O(4) coordination geometry for Ni is completed by an O atom derived from the bridging carboxylate ligand and an oxo O atom. The latter two atoms, along with a terminal oxide group, complete the O5 square-pyramidal coordination geometry for V. Each of the dinuclear compounds, [(acac)Ni(II)L(1)V(IV)O(acac)] (3) and [(dbm)Ni(II)L(1)V(IV)O(dbm)] (4) [Hdbm = dibenzoylmethane], also features a tetradentate (L(1))(2)- ligand, Ni in an octahedral cis-N(2)O(4) coordination geometry, and V in an O(5) square-pyramidal geometry. In 3 and 4, the bridges between the Ni and V atoms are provided by the (L(1))(2)- ligand. The Ni...V separations in the structures lie in the narrow range of 2.9222(4) A (3) to 2.9637(5) A (4). The paramagnetic Ni centers (S = 1) in 1 and 2 are widely separated (Ni...Ni separations are 5.423 and 5.403 A) by the double V(V)O(4) bridge that leads to weak antiferromagnetic interactions (J = -3.6 and -3.9 cm-1) and thus an ST = 0 ground state for these systems. In 3 and 4, the interactions between paramagnetic centers (Ni(II) and V(IV)) are also antiferromagnetic (J = -8.9 and -10.0 cm-1), leading to an S(T) = 1/2 ground state. Compound 4 undergoes two one-electron redox processes at E(1/2) = +0.66 and -1.34 V vs Ag/AgCl reference due to a V(IV/V) oxidation and a Ni(II)/I reduction, respectively, as indicated by cyclic and differential pulse voltammetry.     

4-amino- and 4-nitrodipicolinatovanadium(V) complexes and their hydroxylamido derivatives: synthesis, aqueous, and solid-state properties

A number of 4-substituted, dipicolinatodioxovanadium(V) complexes and their hydroxylamido derivatives were synthesized to characterize the solid state and solution properties of five- and seven-coordinate vanadium(V) complexes. The X-ray crystal structures of Na[VO2dipic-NH2].2H2O (2) and K[VO2dipic-NO2] (3) show the vanadium adopting a distorted, trigonal-bipyramidal coordination environment similar to the parent coordination complex, [VO2dipic]- (1), reported previously as the Cs+ salt. The observed differences in the chemical shifts of the complexes both in the 1H (ca. 0.7-1.4 ppm) and 51V (ca. 1-11 ppm) NMR spectra were consistent with the electron-donating or electron-withdrawing properties of the substituent groups, respectively. Stoichiometric addition of a series of hydroxylamine ligands (H2NOH, MeHNOH, Me2NOH, and Et2NOH) to complexes 1-3 led to the formation of seven-coordinate vanadium(V) complexes. The X-ray crystal structure of [VO(dipic)(Me2NO)(H2O)].0.5H2O (1c) was found to be similar to the previously characterized complexes [VO(dipic)(H2NO)(H2O)] (1a) and [VO(dipic)(OO-tBu)(H2O)]. While only slight differences in the 1H NMR spectra were observed upon addition of the hydroxylamido ligand, the signals in the 51V NMR spectra change by up to 100 ppm. The addition of the hydroxylamido ligand increased the complex stability of complexes 2 and 3. Evidence for a nonstoichiometric redox reaction was found for the monoalkyl hydroxylamine ligand. The reaction of an unsaturated five-coordinate species with a hydroxylamine to form a seven-coordinate vanadium complex will, in general, dramatically increase the amounts of the vanadium compound that remain intact at pH values near neutral.     

Oxovanadium(IV) and -(V) complexes of dithiocarbazate-based tridentate Schiff base ligands: syntheses,structure, and photochemical reactivity of compounds involving imidazole derivatives as coligands

The tridentate dithiocarbazate-based Schiff base ligands H(2)L (S-methyl-3-((5-R-2-hydroxyphenyl)methyl)dithiocarbazate, R = NO(2), L = L(2); R = Br, L = L(3)) react with [VO(acac)(2)] in the presence of imidazole derivatives as coligands to form oxovanadium(IV) and cis-dioxovanadium(V) complexes. With benzimidazole and N-methylimidazole, the products are oxovanadium(IV) complexes, viz. [VOL(3)(BzIm)].0.5CH(3)CN (1a) and [VOL(N-MeIm)(2)] (L = L(3), 1b; L = L(2), 1c), respectively. In both 1a,b, the O and S donor atoms of the tridentate ligand are cis to the terminal oxo group (in the "equatorial" plane) and mutually trans, but the N donor atom is respectively cis and trans to the oxo atom, as revealed from X-ray crystallography. When imidazole or 4-methylimidazole is used as the ancillary ligand, the products obtained are water-soluble cis-dioxovanadium(V) complexes [VO(2)L(R'-ImH)] (L = L(3) and L(2), R' = H and Me, 2a-d). These compounds have zigzag chain structures in the solid state as confirmed by X-ray crystallographic investigations of 2a,d, involving an alternating array of LVO(2)(-) species and the imidazolium counterions held together by Coulombic interactions and strong hydrogen bonding. Complexes 2a-d are stable in water or methanol. In aprotic solvents, viz. CH(3)CN, DMF, or DMSO, however, they undergo photochemical transformation when exposed to visible light. The putative product is a mixed-oxidation divanadium(IV/V) species obtained by photoinduced reduction as established by EPR, electronic spectroscopy, and dynamic (1)H NMR experiments.     

Complexes formed in solution between vanadium(IV)/(V) and the cyclic dihydroxamic acid putrebactin or linear suberodihydroxamic acid

An aerobic solution prepared from V(IV) and the cyclic dihydroxamic acid putrebactin (pbH(2)) in 1:1 H(2)O/CH(3)OH at pH = 2 turned from blue to orange and gave a signal in the positive ion electrospray ionization mass spectrometry (ESI-MS) at m/z(obs) 437.0 attributed to the monooxoV(V) species [V(V)O(pb)](+) ([C(16)H(26)N(4)O(7)V](+), m/z(calc) 437.3). A solution prepared as above gave a signal in the (51)V NMR spectrum at δ(V )= -443.3 ppm (VOCl(3), δ(V) = 0 ppm) and was electron paramagnetic resonance silent, consistent with the presence of [V(V)O(pb)](+). The formation of [V(V)O(pb)](+) was invariant of [V(IV)]:[pbH(2)] and of pH values over pH = 2-7. In contrast, an aerobic solution prepared from V(IV) and the linear dihydroxamic acid suberodihydroxamic acid (sbhaH(4)) in 1:1 H(2)O/CH(3)OH at pH values of 2, 5, or 7 gave multiple signals in the positive and negative ion ESI-MS, which were assigned to monomeric or dimeric V(V)- or V(IV)-sbhaH(4) complexes or mixed-valence V(V)/(IV)-sbhaH(4) complexes. The complexity of the V-sbhaH(4) system has been attributed to dimerization (2[V(V)O(sbhaH(2))](+) ? [(V(V)O)(2)(sbhaH(2))(2)](2+)), deprotonation ([V(V)O(sbhaH(2))](+) - H(+) ? [V(V)O(sbhaH)](0)), and oxidation ([V(IV)O(sbhaH(2))](0) -e(-) ? [V(V)O(sbhaH(2))](+)) phenomena and could be described as the sum of two pH-dependent vectors, the first comprising the deprotonation of hydroxamate (low pH) to hydroximate (high pH) and the second comprising the oxidation of V(IV) (low pH) to V(V) (high pH). Macrocyclic pbH(2) was preorganized to form [V(V)O(pb)](+), which would provide an entropy-based increase in its thermodynamic stability compared to V(V)-sbhaH(4) complexes. The half-wave potentials from solutions of [V(IV)]:[pbH(2)] (1:1) or [V(IV)]:[sbhaH(4)] (1:2) at pH = 2 were E(1/2) -335 or -352 mV, respectively, which differed from the expected trend (E(1/2) [VO(pb)](+/0) < V(V/IV)-sbhaH(4)). The complex solution speciation of the V(V)/(IV)-sbhaH(4) system prevented the determination of half-wave potentials for single species. The characterization of [V(V)O(pb)](+) expands the small family of documented V-siderophore complexes relevant to understanding V transport and assimilation in the biosphere.     

Synthesis and structural characterization of bi- and trimetallic octacyanometalate(IV) complexes: [Delta,Lambda-MII(en)3][cis-MII(en)2(OH2)][MIV(CN)8].2H2O and [cis-MII(en)2(OH2)]2[(mu-NC)2MIV(CN)6].4H2O (MII = Mn, Co, Ni; MIV = Mo, W)

Treatment of [M(II)(en)(3)][OTs](2) or methanolic ethylenediamine solutions containing transition metal p-toluenesulfonates (M(II) = Mn, Co) with aqueous K(4)M(IV)(CN)(8).2H(2)O or Cs(3)M(V)(CN)(8) (M(IV) = Mo, W; M(V) = Mo) affords crystalline clusters of [M(II)(en)(3)][cis-M(II)(en)(2)(OH(2))(mu-NC)M(IV)(CN)(7)].2H(2)O (M(IV) = Mo; M(II) = Mn, 1; Ni, 5; M(IV) = W; M(II) = Mn, 2; Ni, 6) and [cis-M(II)(en)(2)(OH(2))](2)[(mu-NC)(2)M(IV)(CN)(6)].4H(2)O (M(IV) = Mo; M(II) = Co, 3; Ni, 7; M(IV) = W; M(II) = Co, 4) stoichiometry. Each cluster contains cis-M(II)(en)(2)(OH(2))(mu-NC)(2+) units that likely result from dissociative loss of en from [M(II)(en)(3)](2+), affording cis-M(II)(en)(2)(OH(2))(2)(2+) intermediates that are trapped by M(IV)(CN)(8)(4-).